Four practices that sit together because our clients rarely have only one of these problems. A company weighing an SBIR award against a seed round is making one decision about sequencing, not two unrelated ones.
Federal grant strategy for research-driven organisations — programme selection, agency engagement and proposal positioning across NIH, DOE, NSF and DoD.
Government relations and legislative advocacy from Washington — agency engagement, appropriations monitoring and representation before Congress.
Advisory work for companies preparing to raise private capital — readiness, positioning and introductions to investors active in the sector.
Early-stage advisory for research-driven ventures — academic spin-outs, translational research and companies bridging from grant funding to venture capital.
Tell us what you are working on and where the funding gap is. If we are not the right people for it, we will say so and point you at who is.